reference/21351082

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21351082

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	177
issn	2187-2864 0387-821X
issueIdentifier	2
pageRange	165-177
publicationName	Journal of UOEH
startingPage	165
bibliographicCitation	Nie L, Imamura M, Itoh H, Ueno H. Pitavastatin enhances the anti-fibrogenesis effects of candesartan, an angiotensin II receptor blocker, on CCl4-induced liver fibrosis in rats. J UOEH. 2004 Jun 01;26(2):165–77. doi: 10.7888/juoeh.26.165. PMID: 15244070.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b84d2461a5a91596c318a1591da7df3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dbe8eca9255cf3f79d37df5552fb243 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86d76f301844372c925a4c21028b57b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8959e2e1a074258b836fcf764c742084
date	2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.7888/juoeh.26.165 https://pubmed.ncbi.nlm.nih.gov/15244070
isPartOf	https://portal.issn.org/resource/ISSN/2187-2864 https://portal.issn.org/resource/ISSN/0387-821X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7185
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pitavastatin Enhances the Anti-Fibrogenesis Effects of Candesartan, an Angiotensin Ⅱ Receptor Blocker, on CCl4-Induced Liver Fibrosis in Rats
discusses	http://id.nlm.nih.gov/mesh/M0002348 http://id.nlm.nih.gov/mesh/M0001207 http://id.nlm.nih.gov/mesh/M0217705 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0456879 http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0002570 http://id.nlm.nih.gov/mesh/M0024757 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0422150 http://id.nlm.nih.gov/mesh/M0018350 http://id.nlm.nih.gov/mesh/M0003376
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013777Q000627 http://id.nlm.nih.gov/mesh/D000806Q000627 http://id.nlm.nih.gov/mesh/D000959Q000627 http://id.nlm.nih.gov/mesh/D047228 http://id.nlm.nih.gov/mesh/D002251 http://id.nlm.nih.gov/mesh/D001562Q000627 http://id.nlm.nih.gov/mesh/D008103Q000139 http://id.nlm.nih.gov/mesh/D019161Q000627 http://id.nlm.nih.gov/mesh/D008103Q000188 http://id.nlm.nih.gov/mesh/D011804Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013777Q000494 http://id.nlm.nih.gov/mesh/D001713 http://id.nlm.nih.gov/mesh/D016212Q000378 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D001562Q000494 http://id.nlm.nih.gov/mesh/D003864 http://id.nlm.nih.gov/mesh/D000806Q000494 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000959Q000494 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D008099Q000378 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D008103Q000378 http://id.nlm.nih.gov/mesh/D011804Q000494 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D019161Q000494 http://id.nlm.nih.gov/mesh/D051381
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8345 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5943 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4c7375288a9c6143cbc6124b698fd627 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c32c0d8aa4f785d63c80f6f9c7c6be06 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282452 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5810 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245003257 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128111715 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129548391 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127843891

Total number of triples: 74.